Prof. Bing Hu | Global Master in ERCP & Interventional Pancreaticobiliary Endoscopy at West China Hospital

Prof. Bing Hu | Global Master in ERCP & Interventional Pancreaticobiliary Endoscopy at West China Hospital

Executive Clinical Snapshot

Prof. Bing Hu, MD, PhD, FASGE, FJGES, is the Director of the Department of Gastroenterology and Director of the Endoscopy Center at West China Hospital, Sichuan University. Internationally recognized as a premier luminary in therapeutic digestive endoscopy, Prof. Hu holds prestigious fellowships with both the American Society for Gastrointestinal Endoscopy (FASGE) and the Japan Gastroenterological Endoscopy Society (FJGES). He is universally recognized for his unparalleled mastery in Endoscopic Retrograde Cholangiopancreatography (ERCP), interventional Endoscopic Ultrasound (EUS), and digital single-operator cholangiopancreatoscopy (SpyGlass). His technical innovations have established global standards for overcoming anatomical deformities, difficult biliary cannulations, impacted giant stones, and unresectable pancreaticobiliary malignancies without invasive open surgery.

Academic Leadership & International Standing

  • Director, Department of Gastroenterology & Endoscopy Center, West China Hospital, Sichuan University.
  • Fellow of the American Society for Gastrointestinal Endoscopy (FASGE).
  • Fellow of the Japan Gastroenterological Endoscopy Society (FJGES).
  • Vice President, Chinese Society of Digestive Endoscopy (CSDE) & Leader of the National ERCP Expert Group.
  • President / Council Member, Asian-Pacific Association of Gastroenterology (APAGE) Endoscopy Group.
  • Lead Author & International Consensus Panelist for global guidelines on difficult ERCP cannulation, post-ERCP pancreatitis prevention, and endoscopic drainage of walled-off pancreatic necrosis (WOPN).

Endoscopic Innovations: Conquering High-Difficulty Biliary & Pancreatic Tracts

Complex pancreaticobiliary conditions—such as surgically altered gastrointestinal anatomy (Roux-en-Y reconstruction), intrahepatic bile duct lithiasis, and tight tumorous strictures—have traditionally necessitated high-risk laparotomies or external percutaneous biliary drains. Prof. Hu has pioneered endoluminal solutions that spare patients from invasive surgical interventions:

Core Clinical Innovations Spearheaded by Prof. Bing Hu:

  • Difficult Cannulation Algorithms & Pre-Cut Mastery: Achieves a primary biliary cannulation success rate exceeding 99% using specialized dual-guidewire techniques, transpancreatic precut septotomy, and needle-knife fistulotomy, while reducing post-procedure pancreatitis to negligible rates.
  • Digital Single-Operator Cholangioscopy (SpyGlass) & Laser Lithotripsy: Introduces direct visualization micro-endoscopes into intrahepatic bile ducts and the main pancreatic duct, enabling targeted electrohydraulic and holmium laser lithotripsy for rock-hard, impacted stones resistant to conventional mechanical lithotripsy.
  • EUS-Guided Biliary & Pancreatic Drainage (EUS-BD / EUS-PD): Pioneers EUS-guided choledochoduodenostomy (CDS), hepaticogastrostomy (HGS), and rendezvous techniques when retrograde papilla access is anatomically obstructed by duodenal infiltration or postsurgical anatomy.
  • Endoscopic Step-Up Necrosectomy for Walled-Off Pancreatic Necrosis: Employs lumen-apposing metal stents (LAMS) under endosonographic guidance to debride severe infected pancreatic necrosis through transgastric routes, slashing mortality in severe acute pancreatitis.

Comprehensive Endoscopic Scope & Clinical Spectrum

  • Complex Choledocholithiasis & Hepatolithiasis: Impacted giant common bile duct stones, intrahepatic duct lithiasis, and recurrent pyogenic cholangitis managed via ERCP and cholangioscopic laser fragmentation.
  • Biliary Strictures & Cholangiocarcinoma: SpyGlass visual targeted biopsies, radiofrequency ablation (RFA), and deployment of covered/uncovered self-expanding metallic stents (SEMS) for Klatskin tumors and benign biliary anastomotic strictures.
  • Chronic Pancreatitis & Pancreatic Lithiasis: Pancreatic sphincterotomy, mechanical/laser lithotripsy for radiopaque pancreatic duct calculi, and stricture stenting for intractable abdominal pain.
  • Endoscopic Ultrasound (EUS) Interventions: EUS-guided fine-needle biopsy (EUS-FNB) for deep pancreatic masses, celiac plexus neurolysis (CPN) for intractable cancer pain, and pseudocyst drainage.
  • Surgically Altered Anatomy Interventions: Enteroscopy-assisted (balloon enteroscopy) ERCP in patients with Billroth II, Whipple, or Roux-en-Y gastric bypass anatomy.

Benchmark Clinical Scenarios

Scenario A: SpyGlass Laser Lithotripsy for Impacted 3 cm Pancreatic Duct Stone

A 42-year-old software architect suffered from severe recurrent chronic pancreatitis and debilitating epigastric pain caused by a 3.2 cm calculus completely obstructing the pancreatic head. Previous hospital attempts at extracorporeal shockwave lithotripsy (ESWL) failed, and surgical pancreatic resection (Frey procedure) was recommended. Prof. Hu performed an ultra-delicate pancreatic duct cannulation and navigated a SpyGlass digital pancreatoscope directly onto the stone surface. Under continuous saline irrigation, precision holmium laser bursts pulverized the stone into sub-millimeter fragments, which were evacuated with an extraction balloon. The patient became completely pain-free, avoided surgical organ resection, and returned home within 48 hours.

Scenario B: EUS-Guided Hepaticogastrostomy (EUS-HGS) for Obstructive Jaundice in Klatskin Tumor

A 67-year-old female with inoperable Bismuth Type IV hilar cholangiocarcinoma presented with severe hyperbilirubinemia and failed retrograde cannulation due to complete neoplastic obliteration. Instead of placing uncomfortable external percutaneous transhepatic drainage (PTCD) bags, Prof. Hu executed an EUS-guided hepaticogastrostomy. Puncturing the left intrahepatic bile duct transgastrically, a covered metal stent was placed bridging the liver duct directly into the gastric cavity. Serum bilirubin normalized within 7 days, allowing immediate initiation of systemic targeted and immunotherapy.

Scientific Impact & Global Masterclasses

Prof. Bing Hu has authored over 180 scientific articles in premier gastroenterological journals including Gastrointestinal Endoscopy (GIE), Endoscopy, Gut, and The Lancet Gastroenterology & Hepatology. A regular live-demonstration faculty member at prestigious international endoscopy summits (including ASGE Crystal Awards, DDW, and Euro-ERCP), he has trained thousands of endoscopists worldwide in advanced cannulation and pancreaticobiliary intervention techniques.

International Patient Access via CMCS

Cross-border patients experiencing complex jaundice, difficult bile duct stones, pancreatic cysts, or refractory biliary obstructions can coordinate expedited therapeutic evaluation with Prof. Bing Hu at West China Hospital through China Medical Concierge – Shanghai (CMCS):

  • Comprehensive Imaging & Pancreaticobiliary Review: Re-evaluation of multi-detector CT, magnetic resonance cholangiopancreatography (MRCP), and prior procedural endoscopy records prior to travel.
  • Virtual Clinical Second Opinion: Detailed video consultation to evaluate endotherapy feasibility versus open/laparoscopic surgery.
  • Expedited Inpatient Admission & High-Volume Endoscopy Suites: Direct booking into West China Hospital's specialized endoscopy surgical suites, avoiding prolonged outpatient queues.
  • Bilingual Case Coordination: Dedicated clinical case managers facilitating pre-procedure fasting, anesthesia communication, bedside support, and dietary rehabilitation.
  • Post-Procedure Stent Surveillance & Cross-Border Monitoring: Structured digital schedules for stent removal or exchange coordinated seamlessly with home-country gastroenterologists.

Connect with CMCS Medical Concierge

For confidential clinical inquiries, MRCP/CT evaluations, or to schedule an endotherapy consultation with Prof. Bing Hu:

Email: contract@medicalsh.com

WhatsApp: Connect on WhatsApp

Official Website: www.medicalsh.com

댓글 0개

댓글 남기기